For example, miR-200b can target FN1 to regulate EMT in breast cancer cells exhibiting chemoresistance (23), and it can similarly suppress the growth of esophageal squamous carcinoma cells, inducing their cell cycle arrest (24). The gene discussed is FN1; the disease is breast carcinoma.